The invention proposes a new approach to rare genetic diseases for which no cures are available, only symptomatic treatments through the preparation of novel multivalent molecules active toward the human enzymes responsible for them

Settore:

Life sciences

Research Institution:

Università degli Studi di Firenze

Publication number:

WO2017137895A1

TRL:

3

Technologies, Systems, Applications:

Biotechnologies,
New drugs development

Technological Priority:

Biomedical, pharmaceutical, pharmacological technologies,
Biotechnologies for health
Pubblicato il:
Torna in cima alla pagina